InvestorsHub Logo
Followers 36
Posts 1736
Boards Moderated 0
Alias Born 05/13/2011

Re: DewDiligence post# 2023

Wednesday, 03/08/2017 9:23:40 AM

Wednesday, March 08, 2017 9:23:40 AM

Post# of 2795
Yes indeed Dew however my comment was referring to the elaboration on:

(from PR)
-----(Additional results to be presented today include:

Ammonia reduction correlates with clinical improvement, p=0.0006;
Dose proportional response and pharmacokinetic data indicate some patients were under-dosed;
Earlier timing of drug administration and efficacy assessment is important:
- Patients who improve within 48 hours are discharged earlier than patients who do not improve within 48 hours;
- Patients on OCR-002 are more likely to respond within 48 hours compared to placebo, p=0.026;
Pre-defined measures of improvement were statistically significant: ammonia reduction, p=0.017 and Physician overall evaluation, p= 0.026;
OCR-002 demonstrated improvement in the Model for End-Stage Liver Disease (MELD) scores, p=0.051; and
OCR-002 showed improvement in renal function as measured by the change from baseline in Blood Urea Nitrogen (BUN) levels, p=0.04---)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.